Aristotle University Of Thessaloniki (AUTH)
Μελέτη ανάπτυξης μοντέλων αξιολόγησης δομής-δραστικότητας νέων μεταλλοφαρμάκων βαναδίου και ψευδαργύρου με βάση μοριακούς βιοδείκτες ινσουλινομίμησης στο διαβήτη τύπου ΙΙ
Abstract
dc:descriptionDiabetes mellitus (DM) encompasses a group of metabolic syndromes, with a common characteristic being high blood glucose levels. Hyperglycemia emerges as the ultimate phenotypic symptom, following a series of pathological processes related directly or indirectly to the inability or failure to produce insulin. Based on the known pathogenicity of the disease, DM can be either insulin-dependent (DM 1) or insulin-independent (DM 2). DM2 covers approximately 90% of the diagnosed cases worldwide. The currently administered therapeutic protocols, dealing with the disease symptoms, have several disadvantages pertaining to a) elevated oxidative stress in patients exogenously receiving insulin, with a concomitant diminution of their standard of living, and b) a plethora of side-effects from insulin substitutes. The rapid rise of the disease worldwide, the extent and severity of complications emerging in all human physiological systems-organs-tissues, in combination with the lack of effectiveness of contemporary therapeutic drugs, raise an immediate need for new insulin mimetic pharmaceuticals. Especially intimate is the relationship between DM and obesity, both closely associated with adipose tissue, which stores energy in the form of triglycerides and releases free fatty acids, while concurrently acting as an endocrine organ. Furthermore, adipose tissue accumulation, against obesity, is linked to tolerance observed toward insulin. In this respect, the goal of the present study was to evaluate the action of known insulin mimetic metal ions in the insulin metabolic pathway, with emphasis in lipogenesis (adipogenesis), which reflects the main insulin form of activity. The development of potential such pharmaceuticals, capable of inducing pre-adipocyte adipogenesis toward mature adipocytes, rides on the design of metal-organic forms of metal ions Ζn(II), V(IV,V) and Cr(III), with appropriate structurally configured organic substrates, capable of inducing differentiation of their physicochemical properties at the biological level.Zinc is an endogenous trace element, participating in numerous intracellular processes, such as the synthesis and excretion of insulin, the induction of intracellular glucose uptake, while it has been shown that it acts at various points along the signaling pathway activated by insulin. It is not, however, yet fully delineated a) what the role is for zinc mimicking or replacing insulin activity, and b) what the correlation is between the nature of zinc form(s) in relation to the bioactivity it exhibits. Chromium has been shown to play a central role in the metabolism of hydrocarbons, enhancing insulin activity and thus sensitivity toward that hormone, ultimately serving long term therapeutic approaches for DM 2. Vanadium has been described as a non-essential nutritional supplement and an agent necessary in minute amounts, with no however known physiological role of that trace element in humans. Its mechanism of action toward glycemic control is primarily linked to that of insulin, but through re-adjustment of insulin receptors. To that end, plenty of work has been carried out to pursue understanding of the relationship between vanadium and DM, in view of the fact that vanadium mimicks the majority of the immediate effects of insulin, such as glucose uptake and activation of its catabolic pathways.For that reason, a) especially configured organic ligand binders, and b) a family of well-defined complex compounds of Ζn(II), V(IV,V) and Cr(III) have been designed, synthesized and characterized physicochemically (X-ray crystallography, analytical techniques, NMR spectroscopy, FT-IR, TGA-DTG, ESI-MS, etc.). For the structure-dependent and metal-dependent biological investigation of the newly synthesized complex forms of Ζn(II), V(IV,V) and Cr(III) the adipose tissue cell line 3T3-L1 was used, through which careful evaluation took place of a) the (a)toxicity behavior of the title materials, b) the adipogenic potential, and c) the extent of influence in the expression of genes directly or indirectly related to the cellular differentiation (PPAR-γ) and the intracellular glucose uptake (GLUT 1, 4), and d) the expression of glucokinase and adiponectin genes. The results a) show a clear structure-biological activity relationship (cellular survival, migration, adipogenesis) of the discrete forms of Ζn(II), V(IV,V) and Cr(III), and b) set the grounds for the development of molecular technology fighting hyperglycemia through atoxic, bioavailable active forms of Ζn(II), V(IV,V) and Cr(III).Further research into the broader field of peripheral neuropathy and neurotoxicity led to the central nervous system (CNS) and the peripheral nervous system (PNS). They are two especially sensitive tissues, in view of their vulnerability to a plethora of stress factors. In this case, specific metal ions were examined, endogenous or exogenous, potentially toxic to the nervous system as a function of their concentration or the extent of disruption of their homeostasis. For the evaluation of the activity of such metal ionic forms (cobalt, cerium, aluminum, chromium, copper as well as anticancer drugs based on platinum) a model system was employed, encompassing isolated rat sciatic nerves (ex vivo). The model is based on the correlation between viability and action potential generation from stimulated nerve fibers. Nerve viability evaluation can be run through generation of Compound Action Potentials (CAP). In vitro evaluation of metal ionic action was carried out in primary hippocampal cells. Initial evaluation of the potential toxicity action on behalf of the studied metal ionic compounds took place at high concentrations (500 μΜ). The results show that Fe(III) and Al(III) are not toxic, given that CAP is not affected throughout the duration of the experiments. In addition, Co(III) and Ce(III) do not seem to influence significantly the viability of the nerve fibers. On the other hand, Cu(II) and Cr(VI) lower significantly the viability of nerve fibers in a dose-dependent fashion. This observation is tentatively attributed to the production of ROS, in view of the fact that both metal ions are redox active. Moreover, the potential neuroprotective action of n-acetyl cysteine (NAC) and the chelator EDTA was also examined. The results show clearly the neuroprotective role of EDTA, whereas NAC has no influence on the copper-induced toxicity. Finally, the anticancer drugs oxaliplatin and cis-platin seem to influence the potassium voltage-gated channels, in view of the fact that secondary repolarization phases emerge prominently.Collectively, the structure- and metal-dependent behavior of the newly-arisen metal ionic compounds in clinically demanding pathologies reflect on the existence of specific physicochemical characteristics of the organic substrates which, when present, influence profusely the biological activity of the metal ions (DM and peripheral neuropathy). The discoveries in this field of research, through the present doctoral thesis, shed light onto key aspects of clinically important conditions and proffer merit toward further research and employment of safe metallodrugs against aberrational cellular processes in human physiology.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2016
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Tsave, Olga
- Τσαβέ, Όλγα
Subjects
dc:subject × 16- Λιπογένεση
- Σακχαρώδης διαβήτης
- Μεταλλοφάρμακα
- Πειφερική Νευροπάθεια
- Adipogenesis
- Diabetes mellitus
- Meatallodrugs
- Peripheral neuropathy
- Φυσικές Επιστήμες
- Βιολογία
- Επιστήμες Μηχανικού και Τεχνολογία
- Βιοϊατρική Μηχανική
- Natural Sciences
- Biological Sciences
- Engineering and Technology
- Medical Engineering
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/38407